
CRBG
Corebridge Financial Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
35.705
Open
35.140
VWAP
--
Vol
1.82M
Mkt Cap
19.59B
Low
35.020
Amount
--
EV/EBITDA(TTM)
13.70
Total Shares
608.44M
EV
32.36B
EV/OCF(TTM)
16.79
P/S(TTM)
1.25
Corebridge Financial, Inc. is a provider of retirement solutions and insurance products in the United States. The Company partners with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. Its Individual Retirement segment consists of fixed annuities, fixed index annuities, registered index-linked annuities and variable annuities. Its Group Retirement segment consists of recordkeeping, plan administrative and compliance services, financial planning and advisory solutions offered in-plan, along with proprietary and limited non-proprietary annuities, advisory and brokerage products offered out-of-plan. Its Life Insurance segment consists of term and universal life insurance products in the United States. Its Institutional Markets segment consists of stable value wrap (SVW) products, structured settlement and pension risk transfer (PRT) annuities, guaranteed investment contracts (GICs) and corporate markets products.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
4.99B
-0.42%
1.261
+2.51%
5.07B
+11.83%
1.279
-7.29%
4.88B
+16.88%
1.160
+2.65%
Estimates Revision
The market is revising Upward the revenue expectations for Corebridge Financial, Inc. (CRBG) for FY2025, with the revenue forecasts being adjusted by 2.03% over the past three months. During the same period, the stock price has changed by 19.16%.
Revenue Estimates for FY2025
Revise Upward

+2.03%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-2.96%
In Past 3 Month
Stock Price
Go Up

+19.16%
In Past 3 Month
13 Analyst Rating

13.53% Upside
Wall Street analysts forecast CRBG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRBG is 40.45 USD with a low forecast of 35.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Buy
3 Hold
0 Sell
Strong Buy

13.53% Upside
Current: 35.630

Low
35.00
Averages
40.45
High
45.00

13.53% Upside
Current: 35.630

Low
35.00
Averages
40.45
High
45.00
UBS
Sell
to
Neutral
upgrade
$37
2025-07-11
Reason
UBS
Price Target
$37
2025-07-11
upgrade
Sell
to
Neutral
Reason
UBS upgraded Corebridge to Neutral from Sell with a $37 price target.
UBS
Sell
to
Neutral
upgrade
$28 -> $37
2025-07-11
Reason
UBS
Price Target
$28 -> $37
2025-07-11
upgrade
Sell
to
Neutral
Reason
UBS upgraded Corebridge to Neutral from Sell with a price target of $37, up from $28. UBS sees shares as fairly valued following the variable annuity reinsurance deal with Venerable, telling investors that by reinsuring its entire $51B individual VA business, Corebridge monetizes its most complex, low-multiple business for $2.1B of distributable proceeds, and simultaneously validates and eliminates the fundamental downside risk the firm had flagged. The deal materially improves the firm's view of Corebridge's value creation strategy and willingness to adapt, UBS says.
Piper Sandler
Overweight
maintain
$38 -> $40
2025-07-03
Reason
Piper Sandler
Price Target
$38 -> $40
2025-07-03
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Corebridge to $40 from $38 and keeps an Overweight rating on the shares. The firm is reducing its EPS estimates in the space driven by continued fee and spread headwinds. This was confirmed by a rather challenging pre-announcement of variable investment income from MetLife (MET) in late June suggesting this swing factor for a large chunk of lifecoland got sequentially worse, which also - in Piper's opinion - pushes out the normalization factor towards 2026.
Wells Fargo
Overweight
maintain
$37 -> $42
2025-07-01
Reason
Wells Fargo
Price Target
$37 -> $42
2025-07-01
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Corebridge to $42 from $37 and keeps an Overweight rating on the shares. The firm is updating its Corebridge estimates for both Q2 and the recent VA transaction. 2025/2026 EPS estimates go down mostly on loss of earnings from the VA block, while Wells' 2027 EPS estimate and price target go higher.
Morgan Stanley
Overweight
maintain
$37 -> $40
2025-06-27
Reason
Morgan Stanley
Price Target
$37 -> $40
2025-06-27
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on Corebridge to $40 from $37 and keeps an Overweight rating on the shares after the company entered into an agreement with a Venerable subsidiary called CS Life Re to reinsure its Individual Retirement variable annuities business. In exchange for the book, which had an account value of $51B as of Q1-end, Corebridge is generating $2.1B of transaction value on a post-tax basis, or about 12% of its market cap, the analyst noted. Management plans to use most of the $2.1B for share repurchases and a portion for organic growth, the analyst also noted.
BMO Capital
Outperform
maintain
$43 -> $44
2025-06-27
Reason
BMO Capital
Price Target
$43 -> $44
2025-06-27
maintain
Outperform
Reason
BMO Capital raised the firm's price target on Corebridge to $44 from $43 and keeps an Outperform rating on the shares. The company's variable annuity risk transfer bolsters its free cash flow stability, which the firm had already viewed as underappreciated, the analyst tells investors in a research note.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Corebridge Financial Inc (CRBG.N) is 7.19, compared to its 5-year average forward P/E of 5.40. For a more detailed relative valuation and DCF analysis to assess Corebridge Financial Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued
5Y Average PE
5.40
Current PE
7.19
Overvalued PE
6.30
Undervalued PE
4.49
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A
5Y Average EV/EBITDA
4.10
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
8.01
Undervalued EV/EBITDA
0.19
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Overvalued
5Y Average PS
0.70
Current PS
1.00
Overvalued PS
0.82
Undervalued PS
0.58
Financials
Annual
Quarterly
FY2025Q1
YoY :
-38.49%
3.59B
Total Revenue
FY2025Q1
YoY :
-125.84%
-231.00M
Operating Profit
FY2025Q1
YoY :
-179.44%
-657.00M
Net Income after Tax
FY2025Q1
YoY :
-184.40%
-1.19
EPS - Diluted
FY2025Q1
YoY :
-37.29%
375.00M
Free Cash Flow
FY2025Q1
YoY :
-34.75%
11.66
FCF Margin - %
FY2025Q1
YoY :
-229.15%
-18.30
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
4.8M
USD
1
6-9
Months
4.8B
USD
2
0-12
Months
144.3M
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
1
40.0M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 2778.97% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
313.5K
Volume
1
6-9
Months
10.9K
Volume
1
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
4
1.7M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
4.8M
USD
1
6-9
Months
4.8B
USD
2
0-12
Months
144.3M
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
1
40.0M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
CRBG News & Events
Events Timeline
2025-06-26 (ET)
2025-06-26
10:47:26
Corebridge enters $2.8B reinsurance agreement with CS Life Re

2025-05-05 (ET)
2025-05-05
16:29:41
Corebridge reports Q1 operating EPS $1.16, consensus $1.13

2025-02-12 (ET)
2025-02-12
15:16:24
Corebridge reports Q4 operating EPS $1.23, consensus $1.20

Sign Up For More Events
Sign Up For More Events
News
4.0
07-09BenzingaKeefe, Bruyette & Woods Maintains Outperform on Corebridge Financial, Raises Price Target to $42
9.5
07-08Yahoo FinanceCorebridge Financial Schedules Announcement of Second Quarter 2025 Financial Results
4.0
07-08BenzingaJP Morgan Maintains Neutral on Corebridge Financial, Raises Price Target to $40
Sign Up For More News
People Also Watch

PSTG
Pure Storage Inc
57.590
USD
+1.11%

CINF
Cincinnati Financial Corp
149.400
USD
+1.03%

ZBH
Zimmer Biomet Holdings Inc
97.550
USD
+0.70%

CTRA
Coterra Energy Inc
23.630
USD
-0.55%

TECK
Teck Resources Ltd
33.000
USD
-6.04%

IFF
International Flavors & Fragrances Inc
76.630
USD
+0.99%

ILMN
Illumina Inc
109.300
USD
+1.54%

WY
Weyerhaeuser Co
26.470
USD
+3.08%

SBAC
SBA Communications Corp
233.920
USD
-0.51%

RF
Regions Financial Corp
26.420
USD
+0.46%
FAQ

What is Corebridge Financial Inc (CRBG) stock price today?
The current price of CRBG is 35.63 USD — it has increased 1.77 % in the last trading day.

What is Corebridge Financial Inc (CRBG)'s business?

What is the price predicton of CRBG Stock?

What is Corebridge Financial Inc (CRBG)'s revenue for the last quarter?

What is Corebridge Financial Inc (CRBG)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Corebridge Financial Inc (CRBG)'s fundamentals?

How many employees does Corebridge Financial Inc (CRBG). have?
